Stay updated on Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial
Sign up to get notified when there's something new on the Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial page.

Latest updates to the Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedClinicalTrials.gov’s page footer was updated from revision v3.5.2 to v3.5.3, reflecting a site release rather than any change to the trial record.SummaryDifference0.0%

- Check18 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedNo additions or deletions were provided for this page.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed. This appears to be document versioning with no visible changes to the study details presented on the page.SummaryDifference0.0%

- Check55 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check83 days agoChange DetectedFooter now mentions Tuberculosis and includes a link to the Genetic and Rare Diseases Information Center. The revision tag has been updated from v3.4.1 to v3.4.2.SummaryDifference0.2%

Stay in the know with updates to Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial page.